EDQM experts have judged AMINO’s manufacturing processes, including both fermentation and purification at its Frellstedt plant, to be GMP-compliant and suitable for constantly producing amino acids of infusion-grade quality. Isoleucine and threonine are the first amino acids produced via AMINO’s fermentation process to be accepted by the EDQM, notes Dr. Lutz Thomas, AMINO’s managing director, adding: “With these CEPs, AMINO can now place its fermentation-based isoleucine and threonine on the European infusion and pharmaceutical markets. Hence the CEPs mark a significant milestone in the company’s strategy.”

AMINO GmbH, headquartered in Frellstedt, Germany, is a fully integrated producer of specialty amino acids with natural biological origins. Restructured in November 2006, the company is dedicated to producing pharmaceutical-grade and infusion-grade amino acids under strict cGMP standards using the best extraction and purification technology (concentrating on vegetable raw materials) or state-of-the-art biotechnology/fermentation as appropriate.